Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$256M |
| 4 |
Alibaba
BABA
|
+$189M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$82M |
| 2 |
Generac Holdings
GNRC
|
+$33.7M |
| 3 |
Pool Corp
POOL
|
+$32.5M |
| 4 |
Keurig Dr Pepper
KDP
|
+$31M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.28% |
| 2 | Consumer Discretionary | 10.77% |
| 3 | Healthcare | 5.09% |
| 4 | Industrials | 4.03% |
| 5 | Financials | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Evercore
EVR
$11.1B
| $1.02M | 0.01% |
+9,280
| New | +$826K |
|
852
Fox Class B
FOX
$25.9B
| $1.02M | 0.01% |
+35,164
| New | +$974K |
|
853
Arcturus Therapeutics
ARCT
$402M
| $1.01M | 0.01% |
23,302
-13,753
| -37% | -$931K |
|
854
Acushnet Holdings
GOLF
$5.25B
| $1.01M | 0.01% |
+24,897
| New | +$931K |
|
|
AMRS
855
DELISTED
Amyris Inc.
AMRS
| $1.01M | 0.01% |
+163,059
| New | +$521K |
|
|
XENT
856
CALL
DELISTED
Intersect ENT, Inc
XENT
| $1.01M | 0.01% |
+44,700
| New | +$851K |
|
857
Under Armour Class C
UA
$2.24B
| $1M | 0.01% |
67,480
-13,485
| -17% | -$180K |
|
858
Idexx Laboratories
IDXX
$43.9B
| $1M | 0.01% |
+2,004
| New | +$897K |
|
859
ArcelorMittal
MT
$54.9B
| $1M | 0.01% |
43,753
+7,503
| +21% | +$131K |
|
860
Purple Innovation
PRPL
$23.4M
| $1M | 0.01% |
+1,217
| New | +$887K |
|
861
Rockwell Automation
ROK
$47.6B
| $1M | 0.01% |
+3,996
| New | +$977K |
|
862
GoDaddy
GDDY
$12.7B
| $998K | 0.01% |
12,032
-1,175
| -9% | -$92.3K |
|
863
Upwork
UPWK
$1.07B
| $998K | 0.01% |
28,906
-114,275
| -80% | -$3.27M |
|
|
LEAP.U
864
DELISTED
Ribbit LEAP, Ltd. Units, each consisting of one Class A Ordinary Share, and one fifth of one Warrant
LEAP.U
| $997K | 0.01% |
66,600
-3,400
| -5% | -$43K |
|
865
Freshpet
FRPT
$3.69B
| $991K | 0.01% |
+6,978
| New | +$901K |
|
|
PPD
866
DELISTED
PPD, Inc. Common Stock
PPD
| $984K | 0.01% |
28,759
-77,846
| -73% | -$2.72M |
|
|
FSR.WS
867
DELISTED
Fisker Inc. Warrants, each whole warrant exercisable for one Class A common stock at an exercise pri
FSR.WS
| $984K | 0.01% |
+200,000
| New | +$946K |
|
|
PARA
868
DELISTED
Paramount Global Class B
PARA
| $979K | 0.01% |
26,286
-26,755
| -50% | -$858K |
|
869
FNB Corp
FNB
$6.6B
| $977K | 0.01% |
102,818
+40,633
| +65% | +$344K |
|
870
Intuit
INTU
$102B
| $977K | 0.01% |
+2,572
| New | +$903K |
|
871
Agree Realty
ADC
$9.25B
| $974K | 0.01% |
14,627
+94
| +0.6% | +$6.14K |
|
872
Hanover Insurance
THG
$7.91B
| $974K | 0.01% |
8,329
+5,447
| +189% | +$587K |
|
873
ARS Pharmaceuticals
SPRY
$526M
| $968K | 0.01% |
+20,882
| New | +$697K |
|
874
Donaldson
DCI
$10.7B
| $967K | 0.01% |
17,308
+12,486
| +259% | +$659K |
|
875
JPMorgan Chase
JPM
$947B
| $965K | 0.01% |
7,594
-2,962
| -28% | -$331K |
|
Similar funds
Michael Gelband's Q4 2020 Portfolio in Review
As of Q4 2020, Michael Gelband held 2,600 positions worth $10.3B, up 105% from $5.02B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Michael Gelband deployed $4.62B of net new capital in Q4 2020, opening 918 new positions and adding to 493 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Charles Schwab, an estimated $82M trimmed.
- Michael Gelband's largest Q4 2020 buy was State Street SPDR S&P 500 ETF Trust: 352,707 shares worth $132M.
- Michael Gelband added most to Amazon in Q4 2020, an estimated $353M increase.
- Michael Gelband's biggest Q4 2020 reduction was Charles Schwab, cutting an estimated $82M.
- Michael Gelband fully exited Eli Lilly in Q4 2020, selling an estimated $21.7M.
- Michael Gelband's ten largest holdings make up 42% of its $10.3B portfolio in Q4 2020.
- Michael Gelband opened 918 new positions and closed 701 in Q4 2020.
- Michael Gelband's portfolio value rose 105% quarter-over-quarter to $10.3B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.